ObsEva SA: ObsEva Presents Clinical Data on Oral GnRH Antago

-Data featured in two oral presentations at the 8th Society of Endometriosis and Uterine Disorders Congress and a poster presentation at the International Society of Gynecological Endocrinology 20th

Related Keywords

Italy , Geneva , Genè , Switzerland , Athens , Attikír , Greece , Japan , United States , Japanese , Swiss , Karolinska Institutet , Shauna Dillon , Jacques Donnez , Brandi Howard , Hugh Taylor , Kristina Gemzell Danielsson , Yale School Of Medicine , Program In Uterine Fibroids , Society Of Endometriosis , International Society Of Gynecological Endocrinology , European Commission , Drug Administration , International Society , Swiss Exchange , Uterine Disorders Congress , Catholic University Of Louvain , Kisseipharmaceutical Co Ltd , World Congress , Program In Endometriosis , Gynecological Endocrinology , Switzerland May , Uterine Disorders , Chief Clinical Officer , Fibroid Related Heavy Menstrual Bleeding , Women Defined , Without Add Back Therapy , Catholic University , Endometriosis Associated Pain , Efficacy Results , Yale School , Heavy Menstrual Bleeding , Uterine Fibroids , Two Phase , Nasdaq Global Select Market , Central Research Laboratories , Private Securities Litigation Reform Act , Obseva , Presents , Linical , Data , Mural , Snrh , Antagonist , Linzagolix , Multiple , Congresses ,